Consistently, inhibition of PKC or ERK1-ERK2 or upregulation of intracellular cyclic adenosine monophosphate (cAMP) can strongly suppress the nAChR-stimulated responses of SCLC in vitro [65, 66]. The gene discussed is PRRT2; the disease is small cell lung carcinoma.